Revenue (Quarterly) Chart

View Revenue (Quarterly) for KURRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 1.444B
March 31, 2026 1.281B
December 31, 2025 1.396B
September 30, 2025 1.312B
June 30, 2025 1.419B
March 31, 2025 1.278B
December 31, 2024 1.392B
September 30, 2024 1.364B
June 30, 2024 1.406B
March 31, 2024 1.294B
December 31, 2023 1.397B
September 30, 2023 1.338B
June 30, 2023 1.425B
March 31, 2023 1.397B
December 31, 2022 1.437B
September 30, 2022 1.410B
June 30, 2022 1.467B
March 31, 2022 1.441B
December 31, 2021 1.497B
September 30, 2021 1.425B
June 30, 2021 1.443B
March 31, 2021 1.361B
December 31, 2020 1.417B
September 30, 2020 1.241B
June 30, 2020 1.163B
Date Value
March 31, 2020 1.256B
December 31, 2019 1.351B
September 30, 2019 1.318B
June 30, 2019 1.326B
March 31, 2019 1.286B
December 31, 2018 1.357B
September 30, 2018 1.333B
June 30, 2018 1.395B
March 31, 2018 1.377B
December 31, 2017 1.229B
September 30, 2017 1.156B
June 30, 2017 1.125B
March 31, 2017 1.113B
December 31, 2016 1.136B
September 30, 2016 1.140B
June 30, 2016 1.143B
March 31, 2016 1.048B
December 31, 2015 1.069B
September 30, 2015 1.061B
June 30, 2015 1.080B
March 31, 2015
December 31, 2014 1.650B
September 30, 2014 1.114B
June 30, 2014 1.343B
March 31, 2014 1.085B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Nitto Denko Corp. 1.705B
Shin-Etsu Chemical Co., Ltd. 4.157B
LINTEC Corp. 521.97M
Kaneka Corp. 1.400B
Daicel Corp. 956.26M